Follow the 프로젠 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 프로젠 has recorded 81 public disclosures. Market capitalisation: €106.9bn. The latest transaction was filed on 16 July 2026 (Purchase). Among the most active insiders: 에스엘바이젠. All data is free.
79
Insider Decl.
n/a
Thresholds
€542,982
39 ops.
Buy Volume
n/a
21 ops.
Sell Volume
33Σ signal
Buys €542,982n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Progen es una empresa farmacéutica y de atención médica que cotiza en el XKRX. Se enfoca en el desarrollo de tratamientos y soluciones terapéuticas innovadoras.